What is the registration number for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)?

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) is registered under USPTO registration number 6217217.

GEM

USPTO Trademark Record

REGISTERED

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)

Q: Who owns the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) trademark?

The GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) trademark is owned by Sun Pharmaceutical Industries Limited.

Q: What class is the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) trademark registered in?

The GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Q: What is the serial number for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)?

The USPTO serial number for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) is 88125522.

SN 88125522·Reg 6217217·Filed Sep 20, 2018

Owner Sun Pharmaceutical Industries Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) (Serial No. 88125522), Registration No. 6217217, is a registered US trademark filed on Sep 20, 2018 by Sun Pharmaceutical Industries Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Renewal window: December 08, 202660 days remaining

Mark Intelligence

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML) (Reg. #6217217) is a registered US trademark that has been protecting its owner, Sun Pharmaceutical Industries Limited, since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 20, 2018

SERIAL

88125522

REG#

6217217

REGISTERED

Dec 08, 2020

Owner

Applicant

Sun Pharmaceutical Industries Limited

Entity

LLC

Address

Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai, Maharashtra, 400063

Country

Attorney

NameCraig Kuchii, Esq.

Law firm

Craig Kuchii, Esq. SUN PHARMACEUTICAL INDUSTRIES, INC.

Docket

STM-480US

Address

2 INDEPENDENCE WAY, INTELLECTUAL PROPERTY DEPT., PRINCETON, NJ 08540, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 20, 2018

Serial Number88125522

Registration No.6217217

Registration DateDec 08, 2020

Status DateDec 08, 2020

Published for OppositionFeb 26, 2019

Mark TypeDesign with words

Attorney DocketSTM-480US

Status DescriptionLive and registered

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Jul 08, 2020

First use in commerce: Jul 08, 2020

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

First use anywhere: Jul 08, 2020

First use in commerce: Jul 08, 2020

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

38 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Dec 08, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Dec 08, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Nov 04, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Nov 03, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

SOU TEAS EXTENSION RECEIVED

Oct 23, 2020

SOU TEAS EXTENSION RECEIVED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 13, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Oct 13, 2020

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Sep 29, 2020

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Sep 29, 2020

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 24, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Apr 22, 2020

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Apr 22, 2020

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Apr 22, 2020

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 25, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Oct 23, 2019

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Oct 23, 2019

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Oct 23, 2019

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 23, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 26, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 26, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 06, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 18, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Jan 15, 2019

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Jan 15, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 15, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 15, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jan 14, 2019

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jan 08, 2019

WITHDRAWN FROM PUB - OG REVIEW QUERY

ASSIGNED TO LIE

Dec 21, 2018

ASSIGNED TO LIE

EXAMINERS AMENDMENT E-MAILED

Nov 29, 2018

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 29, 2018

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 29, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Nov 29, 2018

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Nov 29, 2018

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Nov 28, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 27, 2018

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 24, 2018

NEW APPLICATION ENTERED

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Sun Pharmaceutical Industries Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Craig Kuchii, Esq.

Resources

Company